Delivery Parameter Variations and Early Clinical Outcomes of Volumetric Modulated Arc Therapy for 31 Prostate Cancer Patients: An Intercomparison of Three Treatment Planning Systems

We created volumetric modulated arc therapy (VMAT) plans for 31 prostate cancer patients using one of three treatment planning systems (TPSs)—ERGO++, Monaco, or Pinnacle—and then treated those patients. A dose of 74 Gy was prescribed to the planning target volume (PTV). The rectum, bladder, and femu...

Full description

Saved in:
Bibliographic Details
Main Authors: Shinichi Tsutsumi, Masako N. Hosono, Daisaku Tatsumi, Yoshitaka Miki, Yutaka Masuoka, Ryo Ogino, Kentaro Ishii, Yasuhiko Shimatani, Yukio Miki
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:The Scientific World Journal
Online Access:http://dx.doi.org/10.1155/2013/289809
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832558877792534528
author Shinichi Tsutsumi
Masako N. Hosono
Daisaku Tatsumi
Yoshitaka Miki
Yutaka Masuoka
Ryo Ogino
Kentaro Ishii
Yasuhiko Shimatani
Yukio Miki
author_facet Shinichi Tsutsumi
Masako N. Hosono
Daisaku Tatsumi
Yoshitaka Miki
Yutaka Masuoka
Ryo Ogino
Kentaro Ishii
Yasuhiko Shimatani
Yukio Miki
author_sort Shinichi Tsutsumi
collection DOAJ
description We created volumetric modulated arc therapy (VMAT) plans for 31 prostate cancer patients using one of three treatment planning systems (TPSs)—ERGO++, Monaco, or Pinnacle—and then treated those patients. A dose of 74 Gy was prescribed to the planning target volume (PTV). The rectum, bladder, and femur were chosen as organs at risk (OARs) with specified dose-volume constraints. Dose volume histograms (DVHs), the mean dose rate, the beam-on time, and early treatment outcomes were evaluated and compared. The DVHs calculated for the three TPSs were comparable. The mean dose rates and beam-on times for Ergo++, Monaco, and SmartArc were, respectively, 174.3 ± 17.7, 149.7 ± 8.4, and 185.8 ± 15.6 MU/min and 132.7 ± 8.4, 217.6 ± 13.1, and 127.5 ± 27.1 sec. During a follow-up period of 486.2 ± 289.9 days, local recurrence was not observed, but distant metastasis was observed in a single patient. Adverse events of grade 3 to grade 4 were not observed. The mean dose rate for Monaco was significantly lower than that for ERGO++ and SmartArc (P<0.0001), and the beam-on time for Monaco was significantly longer than that for ERGO++ and SmartArc (P<0.0001). Each TPS was successfully used for prostate VMAT planning without significant differences in early clinical outcomes despite significant TPS-specific delivery parameter variations.
format Article
id doaj-art-90997491b6e24d06a247c3df30678f62
institution Kabale University
issn 1537-744X
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series The Scientific World Journal
spelling doaj-art-90997491b6e24d06a247c3df30678f622025-02-03T01:31:27ZengWileyThe Scientific World Journal1537-744X2013-01-01201310.1155/2013/289809289809Delivery Parameter Variations and Early Clinical Outcomes of Volumetric Modulated Arc Therapy for 31 Prostate Cancer Patients: An Intercomparison of Three Treatment Planning SystemsShinichi Tsutsumi0Masako N. Hosono1Daisaku Tatsumi2Yoshitaka Miki3Yutaka Masuoka4Ryo Ogino5Kentaro Ishii6Yasuhiko Shimatani7Yukio Miki8Department of Radiology, School of Medicine, Osaka City University, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, JapanDepartment of Radiology, School of Medicine, Osaka City University, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, JapanDepartment of Radiology, Osaka City University Hospital, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, JapanDepartment of Radiology, School of Medicine, Osaka City University, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, JapanDepartment of Radiology, School of Medicine, Osaka City University, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, JapanDepartment of Radiology, School of Medicine, Osaka City University, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, JapanTane Hospital, 1-12-21, Kujo-Minami, Nishi-ku, Osaka 550-0025, JapanDepartment of Radiology, School of Medicine, Osaka City University, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, JapanDepartment of Radiology, School of Medicine, Osaka City University, 1-4-3 Asahi-machi, Abeno-ku, Osaka 545-8585, JapanWe created volumetric modulated arc therapy (VMAT) plans for 31 prostate cancer patients using one of three treatment planning systems (TPSs)—ERGO++, Monaco, or Pinnacle—and then treated those patients. A dose of 74 Gy was prescribed to the planning target volume (PTV). The rectum, bladder, and femur were chosen as organs at risk (OARs) with specified dose-volume constraints. Dose volume histograms (DVHs), the mean dose rate, the beam-on time, and early treatment outcomes were evaluated and compared. The DVHs calculated for the three TPSs were comparable. The mean dose rates and beam-on times for Ergo++, Monaco, and SmartArc were, respectively, 174.3 ± 17.7, 149.7 ± 8.4, and 185.8 ± 15.6 MU/min and 132.7 ± 8.4, 217.6 ± 13.1, and 127.5 ± 27.1 sec. During a follow-up period of 486.2 ± 289.9 days, local recurrence was not observed, but distant metastasis was observed in a single patient. Adverse events of grade 3 to grade 4 were not observed. The mean dose rate for Monaco was significantly lower than that for ERGO++ and SmartArc (P<0.0001), and the beam-on time for Monaco was significantly longer than that for ERGO++ and SmartArc (P<0.0001). Each TPS was successfully used for prostate VMAT planning without significant differences in early clinical outcomes despite significant TPS-specific delivery parameter variations.http://dx.doi.org/10.1155/2013/289809
spellingShingle Shinichi Tsutsumi
Masako N. Hosono
Daisaku Tatsumi
Yoshitaka Miki
Yutaka Masuoka
Ryo Ogino
Kentaro Ishii
Yasuhiko Shimatani
Yukio Miki
Delivery Parameter Variations and Early Clinical Outcomes of Volumetric Modulated Arc Therapy for 31 Prostate Cancer Patients: An Intercomparison of Three Treatment Planning Systems
The Scientific World Journal
title Delivery Parameter Variations and Early Clinical Outcomes of Volumetric Modulated Arc Therapy for 31 Prostate Cancer Patients: An Intercomparison of Three Treatment Planning Systems
title_full Delivery Parameter Variations and Early Clinical Outcomes of Volumetric Modulated Arc Therapy for 31 Prostate Cancer Patients: An Intercomparison of Three Treatment Planning Systems
title_fullStr Delivery Parameter Variations and Early Clinical Outcomes of Volumetric Modulated Arc Therapy for 31 Prostate Cancer Patients: An Intercomparison of Three Treatment Planning Systems
title_full_unstemmed Delivery Parameter Variations and Early Clinical Outcomes of Volumetric Modulated Arc Therapy for 31 Prostate Cancer Patients: An Intercomparison of Three Treatment Planning Systems
title_short Delivery Parameter Variations and Early Clinical Outcomes of Volumetric Modulated Arc Therapy for 31 Prostate Cancer Patients: An Intercomparison of Three Treatment Planning Systems
title_sort delivery parameter variations and early clinical outcomes of volumetric modulated arc therapy for 31 prostate cancer patients an intercomparison of three treatment planning systems
url http://dx.doi.org/10.1155/2013/289809
work_keys_str_mv AT shinichitsutsumi deliveryparametervariationsandearlyclinicaloutcomesofvolumetricmodulatedarctherapyfor31prostatecancerpatientsanintercomparisonofthreetreatmentplanningsystems
AT masakonhosono deliveryparametervariationsandearlyclinicaloutcomesofvolumetricmodulatedarctherapyfor31prostatecancerpatientsanintercomparisonofthreetreatmentplanningsystems
AT daisakutatsumi deliveryparametervariationsandearlyclinicaloutcomesofvolumetricmodulatedarctherapyfor31prostatecancerpatientsanintercomparisonofthreetreatmentplanningsystems
AT yoshitakamiki deliveryparametervariationsandearlyclinicaloutcomesofvolumetricmodulatedarctherapyfor31prostatecancerpatientsanintercomparisonofthreetreatmentplanningsystems
AT yutakamasuoka deliveryparametervariationsandearlyclinicaloutcomesofvolumetricmodulatedarctherapyfor31prostatecancerpatientsanintercomparisonofthreetreatmentplanningsystems
AT ryoogino deliveryparametervariationsandearlyclinicaloutcomesofvolumetricmodulatedarctherapyfor31prostatecancerpatientsanintercomparisonofthreetreatmentplanningsystems
AT kentaroishii deliveryparametervariationsandearlyclinicaloutcomesofvolumetricmodulatedarctherapyfor31prostatecancerpatientsanintercomparisonofthreetreatmentplanningsystems
AT yasuhikoshimatani deliveryparametervariationsandearlyclinicaloutcomesofvolumetricmodulatedarctherapyfor31prostatecancerpatientsanintercomparisonofthreetreatmentplanningsystems
AT yukiomiki deliveryparametervariationsandearlyclinicaloutcomesofvolumetricmodulatedarctherapyfor31prostatecancerpatientsanintercomparisonofthreetreatmentplanningsystems